clinical trial · NCT00649493
Fed Study of Rabeprazole Sodium Tablets 20 mg and Aciphex® Tablets 20 mg
HealthyRabeprazole Sodium Tablets 20 mgAciphex® Tablets 20 mg
brief summary
The objective of this study was to investigate the bioequivalence of Mylan's rabeprazole sodium 20 mg tablets to Eisai's Aciphex® 20 mg tablets following a single, oral 20 mg (1 x 20 mg) dose administration under fed conditions.
started
May 1, 2003
primary completion
Jun 1, 2003
completion
Jun 1, 2003
last updated
Apr 23, 2024
official title
Single-Dose Food In Vivo Bioequivalence Study of Rabeprazole Sodium Tablets (20 mg; Mylan) and Aciphex® Tablets (20 mg; Eisai) in Healthy Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol